- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02848209
Histological Skin Changes of Different Peeling Agents in Surgically Subcutaneous Undermined Skin
Histological Evaluation of Peeling Induced Skin Changes of Different Peeling Agents in Surgically Subcutaneous Undermined Skin Flaps in Facelift Patients
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Written informed consent has to be obtained from 9 random female Caucasian patients aged between 40 and 80 years who will receive a Peeling assisted volume enhancing (PAVE) facelift procedure in Ocean Clinic, Marbella Spain, to take part in the histologic case control study with a within-subjects design.
After completing the facelift, the subcutaneous undermined abundant pre-auricular skin of both sides which is to be resected as consequence of the lift anyhow of each study patient is not resected and split completely in half to yield four samples of the same size, two on each side, without contacting each other in order to prevent any interaction between the peeling agents (n=9 samples per treatment). One sample serves as the control, while the other three samples are each treated with different peeling agents by the same surgeon: Trichloroacetic acid (TCA) peel at concentrations of 20% and 40% and a phenol/croton oil peel. The TCA samples are peeled immediately for 2 to 4 minutes until even frosting and neutralized at the even frosting point. The phenol/croton oil peeled samples are occluded with silicone tape for 24 hours and not neutralized. After 24 hours during the routine in-hospital stay of the patient, the skin samples are resected, the preauricular wound is closed, and all samples are placed in 10 % neutral buffered formalin. The samples are immediately processed, trimmed, embedded, sectioned and stained with haematoxylin and eosin (H&E) by the same researcher. Histological evaluation which will take place in Tuebingen is carried out using a microscope, and pictures are captured at 10x, 25x and 100x magnification using a digital camera. Two trained histological examiners blinded to the study design independently perform histological evaluations. The depth of necrosis in µm is determined by analysing the tissue damage in relation to histological skin layers. All slices are evaluated using light microscopy to assess the mean depth of necrosis in three samples at three different sites for each specimen. The vertical height in µm between the cutaneous basal membrane and the deepest penetration of tissue damage is measured as well as the total thickness of the epidermis and dermis. Based on the histomorphological changes, actual peeling depth is determined and classified analogously to the current classification of burns: superficial, superficial-partial, deep-partial and full thickness.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Malaga
-
Marbella, Malaga, Spain, 29600
- Ocean Clinic
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- The population consists of all female English-speaking Caucasian patients of the Department for plastic and aesthetic surgery of Ocean Clinic Marbella, Spain, between 40 and 80 years seeking for elective facial rejuvenation with the PAVE-lift technique (peeling assisted volume enhancing Facelift) who give formal written informed consent to take part in the study.
Exclusion Criteria:
- any known cardiac problems like arrhythmia or conduction disorders, such as Wolff Parkinson White Syndrome
- previous facelift surgery
- previous facial peeling
- Fitzpatrick skin type 4, 5 and 6 (dark tanned skin types in which the applied peeling agents are known to lead to unpleasant results such as hypopigmentation and skin lightening)
- any former episode of skin cancer
- any inability to give informed written consent
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Non-Randomized
- Interventional Model: Factorial Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
No Intervention: Control
No peeling applied on the skin flap
|
|
Experimental: Drug: TCA 20% Peeling
Trichloroacetic acid 20% applied on the skin flap until even frosting for 2-4 minutes.
|
TCA peel at a concentration of 20% is applied on subcutaneous undermined skin samples for 2 to 4 minutes until even frosting and neutralized at the even frosting Point.
|
Experimental: Drug: TCA 40% Peeling
Trichloroacetic acid 40% applied on the skin flap until even frosting for 2-4 minutes.
|
TCA peel at a concentration of 40% is applied on subcutaneous undermined skin samples for 2 to 4 minutes until even frosting and neutralized at the even frosting Point.
|
Experimental: Drug: Phenol/croton oil Peeling
Phenol/croton oil applied on the skin flap occluded with silicone tape for 24 hours and not neutralized.
|
Phenol/croton oil is applied on subcutaneous undermined skin samples and occluded with silicone tape for 24 hours and not neutralized.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Peeling depth
Time Frame: 24 hours
|
The vertical height in µm between the cutaneous basal membrane and the deepest penetration of tissue damage is measured as well as the total thickness of the epidermis and dermis
|
24 hours
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Chemical burn grade
Time Frame: 24 hours
|
Based on the histomorphological changes, actual peeling depth is determined and classified analogously to the current classification of burns: superficial, superficial-partial, deep-partial and full thickness.
|
24 hours
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Phillipp Gonser, MD, BG Trauma Centre Tuebingen
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- PEEL1
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Burn of Face, Head and/or Neck
-
Rady Children's Hospital, San DiegoUnknownCyst of Face, Neck or Shoulder | Pilomatrixoma of Face, Neck or ShoulderUnited States
-
The University of Texas Health Science Center,...Enrolling by invitationHead and Neck Cancer | Lymphedema of FaceUnited States
-
Jeff Elias, MDRecruitingCancer of Head and Neck | Pain, Neck | Pain, FaceUnited States
-
Izmir Bakircay UniversityGazi UniversityCompletedHead and Neck Cancer | Lymphedema of Face | Fibrosis; SkinTurkey
-
Masaryk Memorial Cancer InstituteUnknownMalignant Tumor of Soft Tissue of Head, Face and NeckCzechia
-
Ethicon, Inc.TerminatedPtosis of the Neck, Mid-face and/or JowlIsrael, France, Germany, United Kingdom
-
University Hospital, GhentFund for Scientific Research, Flanders, BelgiumCompleted
-
Peking University Third HospitalRecruitingMalignant Tumor of Head and/or NeckChina
-
Robert FerrisAmgenCompletedHead and Neck Cancer | Cancer of Head and Neck | Head Cancer | Neck Cancer | Neoplasms, Head and Neck | Cancer of the Head and Neck | Cancer of Neck | Upper Aerodigestive Tract Neoplasms | Neck Neoplasms | Cancer of the Head | Cancer of the Neck | UADT Neoplasms | Cancer of Head | Head Neoplasms | Head, Neck Neoplasms | Neoplasms, Head and other conditionsUnited States
-
Teoxane SAActive, not recruitingSkin Aging | Fine Lines of the Face and NeckSpain
Clinical Trials on TCA 20% Peeling
-
Cairo UniversityCompletedKeratosis PilarisEgypt
-
Rush Eye AssociatesActive, not recruitingDiabetic Retinopathy Visually ThreateningMexico
-
Samsung Medical CenterCompleted
-
Nova Scotia Health AuthorityRecruiting
-
Federal University of São PauloUnknown
-
Assiut UniversityNot yet recruiting
-
Allotex, Inc.WithdrawnHyperopiaAustria, Belgium, France, Ireland, Switzerland, United Kingdom
-
Assistance Publique - Hôpitaux de ParisCompleted
-
Henry Ford Health SystemCompletedPost-inflammatory HyperpigmentationUnited States